Global Inactivated Polio Vaccine Market Insights, Forecast to 2028

Table Of Contents

1 Study Coverage

1.1 Inactivated Polio Vaccine Product Introduction 1.2 Market by Type 1.2.1 Global Inactivated Polio Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Government 1.2.3 Private Sector 1.3 Market by Application 1.3.1 Global Inactivated Polio Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Pediatrics 1.3.3 Adults 1.4 Study Objectives 1.5 Years Considered2 Executive Summary 2.1 Global Inactivated Polio Vaccine Sales Estimates and Forecasts 2017-2028 2.2 Global Inactivated Polio Vaccine Revenue Estimates and Forecasts 2017-2028 2.3 Global Inactivated Polio Vaccine Revenue by Region: 2017 VS 2021 VS 2028 2.4 Global Inactivated Polio Vaccine Sales by Region 2.4.1 Global Inactivated Polio Vaccine Sales by Region (2017-2022) 2.4.2 Global Sales Inactivated Polio Vaccine by Region (2023-2028) 2.5 Global Inactivated Polio Vaccine Revenue by Region 2.5.1 Global Inactivated Polio Vaccine Revenue by Region (2017-2022) 2.5.2 Global Inactivated Polio Vaccine Revenue by Region (2023-2028) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa3 Competition by Manufacturers 3.1 Global Inactivated Polio Vaccine Sales by Manufacturers 3.1.1 Global Top Inactivated Polio Vaccine Manufacturers by Sales (2017-2022) 3.1.2 Global Inactivated Polio Vaccine Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Inactivated Polio Vaccine in 2021 3.2 Global Inactivated Polio Vaccine Revenue by Manufacturers 3.2.1 Global Inactivated Polio Vaccine Revenue by Manufacturers (2017-2022) 3.2.2 Global Inactivated Polio Vaccine Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Inactivated Polio Vaccine Revenue in 2021 3.3 Global Inactivated Polio Vaccine Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Inactivated Polio Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Inactivated Polio Vaccine Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans4 Market Size by Type 4.1 Global Inactivated Polio Vaccine Sales by Type 4.1.1 Global Inactivated Polio Vaccine Historical Sales by Type (2017-2022) 4.1.2 Global Inactivated Polio Vaccine Forecasted Sales by Type (2023-2028) 4.1.3 Global Inactivated Polio Vaccine Sales Market Share by Type (2017-2028) 4.2 Global Inactivated Polio Vaccine Revenue by Type 4.2.1 Global Inactivated Polio Vaccine Historical Revenue by Type (2017-2022) 4.2.2 Global Inactivated Polio Vaccine Forecasted Revenue by Type (2023-2028) 4.2.3 Global Inactivated Polio Vaccine Revenue Market Share by Type (2017-2028) 4.3 Global Inactivated Polio Vaccine Price by Type 4.3.1 Global Inactivated Polio Vaccine Price by Type (2017-2022) 4.3.2 Global Inactivated Polio Vaccine Price Forecast by Type (2023-2028)5 Market Size by Application 5.1 Global Inactivated Polio Vaccine Sales by Application 5.1.1 Global Inactivated Polio Vaccine Historical Sales by Application (2017-2022) 5.1.2 Global Inactivated Polio Vaccine Forecasted Sales by Application (2023-2028) 5.1.3 Global Inactivated Polio Vaccine Sales Market Share by Application (2017-2028) 5.2 Global Inactivated Polio Vaccine Revenue by Application 5.2.1 Global Inactivated Polio Vaccine Historical Revenue by Application (2017-2022) 5.2.2 Global Inactivated Polio Vaccine Forecasted Revenue by Application (2023-2028) 5.2.3 Global Inactivated Polio Vaccine Revenue Market Share by Application (2017-2028) 5.3 Global Inactivated Polio Vaccine Price by Application 5.3.1 Global Inactivated Polio Vaccine Price by Application (2017-2022) 5.3.2 Global Inactivated Polio Vaccine Price Forecast by Application (2023-2028)6 North America 6.1 North America Inactivated Polio Vaccine Market Size by Type 6.1.1 North America Inactivated Polio Vaccine Sales by Type (2017-2028) 6.1.2 North America Inactivated Polio Vaccine Revenue by Type (2017-2028) 6.2 North America Inactivated Polio Vaccine Market Size by Application 6.2.1 North America Inactivated Polio Vaccine Sales by Application (2017-2028) 6.2.2 North America Inactivated Polio Vaccine Revenue by Application (2017-2028) 6.3 North America Inactivated Polio Vaccine Market Size by Country 6.3.1 North America Inactivated Polio Vaccine Sales by Country (2017-2028) 6.3.2 North America Inactivated Polio Vaccine Revenue by Country (2017-2028) 6.3.3 U.S. 6.3.4 Canada7 Europe 7.1 Europe Inactivated Polio Vaccine Market Size by Type 7.1.1 Europe Inactivated Polio Vaccine Sales by Type (2017-2028) 7.1.2 Europe Inactivated Polio Vaccine Revenue by Type (2017-2028) 7.2 Europe Inactivated Polio Vaccine Market Size by Application 7.2.1 Europe Inactivated Polio Vaccine Sales by Application (2017-2028) 7.2.2 Europe Inactivated Polio Vaccine Revenue by Application (2017-2028) 7.3 Europe Inactivated Polio Vaccine Market Size by Country 7.3.1 Europe Inactivated Polio Vaccine Sales by Country (2017-2028) 7.3.2 Europe Inactivated Polio Vaccine Revenue by Country (2017-2028) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia8 Asia Pacific 8.1 Asia Pacific Inactivated Polio Vaccine Market Size by Type 8.1.1 Asia Pacific Inactivated Polio Vaccine Sales by Type (2017-2028) 8.1.2 Asia Pacific Inactivated Polio Vaccine Revenue by Type (2017-2028) 8.2 Asia Pacific Inactivated Polio Vaccine Market Size by Application 8.2.1 Asia Pacific Inactivated Polio Vaccine Sales by Application (2017-2028) 8.2.2 Asia Pacific Inactivated Polio Vaccine Revenue by Application (2017-2028) 8.3 Asia Pacific Inactivated Polio Vaccine Market Size by Region 8.3.1 Asia Pacific Inactivated Polio Vaccine Sales by Region (2017-2028) 8.3.2 Asia Pacific Inactivated Polio Vaccine Revenue by Region (2017-2028) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines9 Latin America 9.1 Latin America Inactivated Polio Vaccine Market Size by Type 9.1.1 Latin America Inactivated Polio Vaccine Sales by Type (2017-2028) 9.1.2 Latin America Inactivated Polio Vaccine Revenue by Type (2017-2028) 9.2 Latin America Inactivated Polio Vaccine Market Size by Application 9.2.1 Latin America Inactivated Polio Vaccine Sales by Application (2017-2028) 9.2.2 Latin America Inactivated Polio Vaccine Revenue by Application (2017-2028) 9.3 Latin America Inactivated Polio Vaccine Market Size by Country 9.3.1 Latin America Inactivated Polio Vaccine Sales by Country (2017-2028) 9.3.2 Latin America Inactivated Polio Vaccine Revenue by Country (2017-2028) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina10 Middle East and Africa 10.1 Middle East and Africa Inactivated Polio Vaccine Market Size by Type 10.1.1 Middle East and Africa Inactivated Polio Vaccine Sales by Type (2017-2028) 10.1.2 Middle East and Africa Inactivated Polio Vaccine Revenue by Type (2017-2028) 10.2 Middle East and Africa Inactivated Polio Vaccine Market Size by Application 10.2.1 Middle East and Africa Inactivated Polio Vaccine Sales by Application (2017-2028) 10.2.2 Middle East and Africa Inactivated Polio Vaccine Revenue by Application (2017-2028) 10.3 Middle East and Africa Inactivated Polio Vaccine Market Size by Country 10.3.1 Middle East and Africa Inactivated Polio Vaccine Sales by Country (2017-2028) 10.3.2 Middle East and Africa Inactivated Polio Vaccine Revenue by Country (2017-2028) 10.3.3 Turkey 10.3.4 Saudi Arabia11 Company Profiles 11.1 Sanofi 11.1.1 Sanofi Corporation Information 11.1.2 Sanofi Overview 11.1.3 Sanofi Inactivated Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Sanofi Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Sanofi Recent Developments 11.2 GSK 11.2.1 GSK Corporation Information 11.2.2 GSK Overview 11.2.3 GSK Inactivated Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 GSK Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 GSK Recent Developments 11.3 Bibcol 11.3.1 Bibcol Corporation Information 11.3.2 Bibcol Overview 11.3.3 Bibcol Inactivated Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Bibcol Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Bibcol Recent Developments 11.4 Serum Institute 11.4.1 Serum Institute Corporation Information 11.4.2 Serum Institute Overview 11.4.3 Serum Institute Inactivated Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 Serum Institute Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 Serum Institute Recent Developments 11.5 Tiantan Biological 11.5.1 Tiantan Biological Corporation Information 11.5.2 Tiantan Biological Overview 11.5.3 Tiantan Biological Inactivated Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Tiantan Biological Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Tiantan Biological Recent Developments 11.6 Panacea Biotec 11.6.1 Panacea Biotec Corporation Information 11.6.2 Panacea Biotec Overview 11.6.3 Panacea Biotec Inactivated Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Panacea Biotec Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Panacea Biotec Recent Developments 11.7 Bio-Med 11.7.1 Bio-Med Corporation Information 11.7.2 Bio-Med Overview 11.7.3 Bio-Med Inactivated Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Bio-Med Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Bio-Med Recent Developments 11.8 Halfkin Bio-Pharmaceuticals 11.8.1 Halfkin Bio-Pharmaceuticals Corporation Information 11.8.2 Halfkin Bio-Pharmaceuticals Overview 11.8.3 Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Sales, Price, Revenue and Gross Margin (2017-2022) 11.8.4 Halfkin Bio-Pharmaceuticals Inactivated Polio Vaccine Product Model Numbers, Pictures, Descriptions and Specifications 11.8.5 Halfkin Bio-Pharmaceuticals Recent Developments12 Industry Chain and Sales Channels Analysis 12.1 Inactivated Polio Vaccine Industry Chain Analysis 12.2 Inactivated Polio Vaccine Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Inactivated Polio Vaccine Production Mode & Process 12.4 Inactivated Polio Vaccine Sales and Marketing 12.4.1 Inactivated Polio Vaccine Sales Channels 12.4.2 Inactivated Polio Vaccine Distributors 12.5 Inactivated Polio Vaccine Customers13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Inactivated Polio Vaccine Industry Trends 13.2 Inactivated Polio Vaccine Market Drivers 13.3 Inactivated Polio Vaccine Market Challenges 13.4 Inactivated Polio Vaccine Market Restraints14 Key Findings in The Global Inactivated Polio Vaccine Study15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer